In the TPX2 co-expression module, the synergistic effect between CENPF and FOXM1 were found to activate prostate malignancies; experimental verification showed that the synergistic effect of FOXM1 and CENPF promoted tumor growth by activating key signaling pathways and acted as an important marker of tumor prognosis and survival [22]. This evidence concerns the gene TPX2 and neoplasm.